Artery Research

Volume 12, Issue C, December 2015, Pages 15 - 15

P4.2 CORONARY RISK IN RELATION TO GENETIC VARIATION IN MEOX2 AND TCF15 IN A FLEMISH POPULATION

Authors
Wen-Yi Yang1, Thibault Petit1, Lutgard Thijs1, Zhen-Yu Zhang1, Lotte Jacobs1, Azusa Hara1, Fang-Fei Wei1, Erika Salvi2, Lorena Citterio3, Yu-Mei Gu1, Judita Knez1, Nicholas Cauwenberghs1, Matteo Barcella2, Cristina Barlassina2, Paolo Manuta3, Tatiana Kuznetsova*1, Daniele Cusi2, Peter Verhamme1, Aernout Luttun1, Jan Staessen1, 4
1University of Leuven, Leuven, Belgium
2University of Milan, Milan, Italy
3University Vita-Salute Raffaele, Milan, Italy
4Maastricht University, Maastricht, The Netherlands
Available Online 23 November 2015.
DOI
10.1016/j.artres.2015.10.246How to use a DOI?
Abstract

Aims: In mice, MEOX2/TCF15 heterodimers are highly expressed in heart endothelial cells and are involved in the transcriptional regulation of lipid transport. We investigated whether coronary heart disease (CHD) in humans is associated with variation in these genes.

Methods and results: In 2027 participants enrolled in the Flemish Study on Environment, Genes and Health Outcomes (51.0% women; mean age 43.6 years), we genotyped SNPs in MEOX2 and TCF15, measured baseline cardiovascular risk factors, and recorded CHD incidence. Over 15.2 years (median), CHD occurred in 106 participants. For SNPs, we contrasted minor-allele heterozygotes and homozygotes (variant) vs. major-allele homozygotes (reference) and for haplotypes carriers vs. non-carriers. Sex- and age-standardised CHD rates were higher in MEOX2 rs10777, rs12056299, rs7787043, rs4532497, rs1050290 variants, in MEOX2 GTCCGC haplotype carriers (prevalence, 16.5%), but lower in MEOX2 rs6959056 variants (P ≤ 0.04, adjusted for multiple testing). In multivariable-adjusted analyses, the corresponding hazard ratios were ≥1.50 (P ≤ 0.049), 1.77 (P = 0.0054) and 0.62 (P = 0.025), respectively. None of four TCF15 SNPs was associated with coronary risk (P ≥ 0.29). However, CHD risk associated with MEOX2 rs4532497 was confined to TCF15 rs12624577 variant allele carriers (P for interaction = 0.011). The MEOX2 GTCCGC hap-lotype significantly improved the prediction of CHD over and beyond traditional risk factors and was associated with similar population-attributable risk as smoking (18.7% vs. 16.2%).

Conclusions: In randomly recruited Flemish, genetic variation in MEOX2, but not TCF15, is a strong predictor of CHD. Further experimental studies should elucidate the underlying molecular mechanisms.

Open Access
This is an open access article distributed under the CC BY-NC license.

Download article (PDF)
View full text (HTML)

Journal
Artery Research
Volume-Issue
12 - C
Pages
15 - 15
Publication Date
2015/11/23
ISSN (Online)
1876-4401
ISSN (Print)
1872-9312
DOI
10.1016/j.artres.2015.10.246How to use a DOI?
Open Access
This is an open access article distributed under the CC BY-NC license.

Cite this article

TY  - JOUR
AU  - Wen-Yi Yang
AU  - Thibault Petit
AU  - Lutgard Thijs
AU  - Zhen-Yu Zhang
AU  - Lotte Jacobs
AU  - Azusa Hara
AU  - Fang-Fei Wei
AU  - Erika Salvi
AU  - Lorena Citterio
AU  - Yu-Mei Gu
AU  - Judita Knez
AU  - Nicholas Cauwenberghs
AU  - Matteo Barcella
AU  - Cristina Barlassina
AU  - Paolo Manuta
AU  - Tatiana Kuznetsova*
AU  - Daniele Cusi
AU  - Peter Verhamme
AU  - Aernout Luttun
AU  - Jan Staessen
PY  - 2015
DA  - 2015/11/23
TI  - P4.2 CORONARY RISK IN RELATION TO GENETIC VARIATION IN MEOX2 AND TCF15 IN A FLEMISH POPULATION
JO  - Artery Research
SP  - 15
EP  - 15
VL  - 12
IS  - C
SN  - 1876-4401
UR  - https://doi.org/10.1016/j.artres.2015.10.246
DO  - 10.1016/j.artres.2015.10.246
ID  - Yang2015
ER  -